Integra LifeSciences to Host Third Quarter 2024 Financial Results Conference Call on November 4, 2024

IART 10.14.2024

Full Press ReleaseSEC FilingsOur IART Tweets

About Gravity Analytica

Recent News

  • 01.14.2025 - Integra LifeSciences Launches Integra Institute for Healthcare Professionals (HCPs)
  • 01.10.2025 - Mojdeh Poul
  • 11.13.2024 - Integra’s DuraSeal® Dural Sealant Saves Healthcare Costs According to an Economic Evaluation Published in the Journal of Comparative Effectiveness Research

Recent Filings

  • 01.08.2025 - 4 Statement of changes in beneficial ownership of securities
  • 01.07.2025 - 3 Initial statement of beneficial ownership of securities
  • 01.06.2025 - 8-K Current report
PDF Version

PRINCETON, N.J., Oct. 14, 2024 (GLOBE NEWSWIRE) --Integra LifeSciences Holdings Corporation(NASDAQ: IART), a leading global medical technology company, will release third quarter 2024 financial results on Monday, November 4, 2024, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET.

A live webcast will be available on the Investors section of the Company’s website atinvestor.integralife.com. For those planning to participate on the call, registerhereto receive dial-in details and an individual pin. While not required, joining 10 minutes before the event starts is recommended. A webcast replay of the conference call will be available on theInvestors section of the Company’s websitefollowing the call.

About Integra LifeSciences

At Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate treatment pathways to advance patient outcomes and set new standards of surgical, neurologic and regenerative care. We offer a comprehensive portfolio of high quality, leadership brands. For the latest news and information about Integra and its products, please visitwww.integralife.com.

Investor Relations:Chris Ward(609) 772-7736chris.ward@integralife.com

Media Contact:Laurene Isip(609) 208-8121laurene.isip@integralife.com

Integra LifeSciences Holdings Corporation

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com